maliqun61 schreef op 8 februari 2022 11:33:
[...]
02/01 Morgan Stanley Adjusts Pharvaris' Price Target to $41 from $50, Keeps Overweight Rating MT
2021 PHARVARIS B : Oppenheimer Initiates Coverage on Pharvaris With Outperform Rating, $48 Pric.. MT
2021 PHARVARIS B : Morgan Stanley Starts Pharvaris BV at Overweight With $51 Price Target MT
2021 PHARVARIS B : BofA Securities Starts Pharvaris BV at Neutral With $41 Price Target
2021 PHARVARIS B : SVB Leerink Starts Pharvaris BV at Outperform With $50 Price Target MT